Acute care utilization due to hospitalizations for pediatric lower respiratory tract infections in British Columbia, Canada

BMC Health Services Research

Volumn 12, Issue 1, 2012, Pages

  Santibanez, Pablo ^a   Gooch, Katherine ^b   Vo, Pamela ^b   Lorimer, Michelle ^c   Sandino, Yurik ^d  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b ABBOTT LABORATORIES   (United States)

^c Lorimer Enterprises Inc   (Canada)

^d FRASER HEALTH AUTHORITY   (Canada)

Author keywords

Acute care resource utilization; British Columbia; Lower respiratory tract infection; Pediatrics

Indexed keywords

ADOLESCENT; ARTICLE; CANADA; CHILD; CLASSIFICATION; CONFIDENCE INTERVAL; FACTUAL DATABASE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; INFANT; INTENSIVE CARE; LENGTH OF STAY; PRESCHOOL CHILD; RESPIRATORY TRACT INFECTION; UTILIZATION REVIEW;

ADOLESCENT; BRITISH COLUMBIA; CHILD; CHILD, PRESCHOOL; CONFIDENCE INTERVALS; CRITICAL CARE; DATABASES, FACTUAL; HEALTH CARE COSTS; HOSPITALIZATION; HUMANS; INFANT; LENGTH OF STAY; RESPIRATORY TRACT INFECTIONS;

MLCS; MLOWN;

EID: 84870550859     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-12-451     Document Type: Article

References (26)

1. Impact of severe disease caused by respiratory syncytial virus in children living in developed countries. Simoes EA, Carbonell-Estrany X, Pediatr Infect Dis J 2003 22 13 S20 12671448
2. Economic evaluation of respiratory syncytial virus infection in Canadian children: a Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study. Langley JM, Wang EEL, Law BJ, Stephens D, Boucher FD, Dobson S, McDonald J, MacDonald NE, Mitchell I, Robinson JL, J Pediatr 1997 131 113 117 10.1016/S0022-3476(97)70133-1 9255201 (Pubitemid 27498318)
3. Association of RSV lower respiratory tract infection and subsequent healthcare use and costs: a Medicaid claims analysis in early-preterm, late-preterm, and full-term infants. Shi N, Palmer L, Chu BC, Katkin JP, Hall CB, Masaquel AS, Mahadevia PJ, J Med Econ 2011 14 3 335 340 10.3111/13696998. 2011.578188 21524154
4. A decade of respiratory syncytial virus epidemiology and prophylaxis: Translating evidence into everyday clinical practice. Paes BA, Mitchell I, Banerji A, Lanctot KL, Langley JM, Can Respir J 2011 18 2 10 e19 21499597
5. An update on respiratory syncytial virus epidemiology: a developed country perspective. Law BJ, Carbonell-Estrany X, Simoes EA, Respir Med 2002 96 SB 1 S7 12201077
6. Increasing incidence of hospitalization for bronchiolitis among Canadian children, 1980-2000. Langley JM, LeBlanc JC, Smith B, Wang EE, J Infect Dis 2003 188 11 1764 1767 10.1086/379740 14639549 (Pubitemid 38010688)
7. Hospitalization attributable to influenza and other viral respiratory illnesses in Canadian children. Schanzer DL, Langley JM, Tam TW, Pediatr Infect Dis J 2006 25 795 800 10.1097/01.inf.0000232632.86800.8c 16940836 (Pubitemid 44334824)
8. Variation in the timing of respiratory syncytial virus outbreaks. Lessons from national surveillance. Panozzo CA, Fowlkes AL, Anderson LJ, Pediatr Infect Dis J 2007 26 41 S45 10.1097/INF.0b013e318157da82 18090199 (Pubitemid 350295029)
9. Critically ill patients with 2009 influenza A (H1N1) infection in Canada. Canadian Critical Care Trials Group H1N1 Collaborative, JAMA 2009 302 17 1872 1879 10.1001/jama.2009.1496 19822627
10. The public's response to the 2009 H1N1 influenza pandemic. SteelFisher GK, Blendon RJ, Bekheit MM, Lubell K, N Engl J Med 2010 362 22 65 10.1056/NEJMp1005102 20484390
11. Vitamin use among children attending a Canadian pediatric emergency department. Goldman RD, Vohra S, Rogovik AL, Fundam Clin Pharmacol 2011 25 1 131 137 10.1111/j.1472-8206.2010.00816.x 20199586
12. Potential vitamin-drug interactions in children: at a pediatric emergency department. Goldman RD, Vohra S, Rogovik AL, Paediatr Drugs 2009 11 4 251 257 10.2165/00148581-200911040-00004 19566109
13. BC Stats, Population extrapolation for organization planning with less error (p.e.o.p.l.e.), run cycle 35 Victoria, British Columbia: British Columbia Ministry of Management Services 2010
14. Canadian Institute for Health Information, Discharge abstract database (DAD), acute care hospitalizations for the province of British Columbia 2011
15. World Health Organization, International Statistical Classification of Disease and Related Health Problems, Tenth Revision (ICD-10) Geneva: World Health Organization 2010
16. Environmental and demographic risk factors for respiratory syncytial virus lower respiratory tract disease. Simoes EA, J Pediatr 2003 143 118 S126 10.1067/S0022-3476(03)00511-0 14615710
17. MedCalc software, version 12.1 Mariakerke, Belgium http://www.medcalc. org/
18. Hand washing and respiratory illness among young adults in military training. Ryan MAK, Christian RS, Wohlrabe J, Am J Prev Med 2001 21 2 79 83 10.1016/S0749-3797(01)00323-3 11457626 (Pubitemid 32660420)
19. Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC) study of admission and management variation in patients hospitalized with respiratory syncytial viral lower respiratory tract infection. Wang EEL, Law BJ, Boucher FD, Stephens D, Robinson JL, Dobson S, Langley JM, McDonald J, MacDonald NE, Mitchell I, J Pediatr 1996 129 3 390 395 10.1016/S0022-3476(96) 70071-9 8804328 (Pubitemid 27484145)
20. Morbidity and mortality after RSV-associated hospitalizations among premature Canadian infants. Sampalis JS, J Pediatr 2003 143 S5 150 S156 14615714
21. Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention. Stewart DL, Romero JR, Buysman EK, Fernandes AW, Mahadevia PJ, Curr Med Res Opin 2009 25 2795 2804 19788406
22. Statistics Canada, Population projections for Canada, provinces and territories 2009-2036. Catalogue no. 91-520-X Ottawa, Ontario: Statistics Canada 2010 22471314
23. Hand washing and cohorting in prevention of hospital acquired infections with respiratory syncytial virus. Isaacs D, Dickson H, O'Callaghan C, Sheaves R, Winter A, Moxon ER, Arch Dis Child 1991 66 227 231 10.1136/adc.66.2.227 2001109
24. Preventing respiratory syncytial virus in homebound premature infants. Austin J, Home Healthc Nurse 2007 25 429 432 10.1097/01.NHH.0000281609.58553.7f 17667001
25. Vaccine development for capsulate bacteria causing pneumonia. Russell FM, Buttery J, Curr Opinion Pul Med 2003 9 227 232 10.1097/00063198-200305000-00012 (Pubitemid 36432899)
26. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. The IMpact-RSV Study Group, Pediatrics 1998 102 3 Pt1 531 537 9738173